New drug formula tested for safety in seniors
NCT ID NCT07456800
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tested a new drug called Lyt-100 (deupirfenidone) in 116 healthy adults aged 60-80 to see how safe it is and how the body processes it compared to the existing drug pirfenidone. The goal was to find the best dose for future studies, not to treat any disease. Participants received different doses of Lyt-100, pirfenidone, or a placebo in a blinded, crossover design.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PHARMACOKINETIC ANALYSIS are added.
By submitting, you agree to our Terms of use
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Accel Research Sites
Lake Mary, Florida, 32746, United States
-
Collaborative Neuroscience Network, LLC.
Long Beach, California, 90806, United States
-
Hassman Research
Berlin, New Jersey, 08009, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.